Vanguard Group’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-899,510
| Closed | -$9.27M | – | 4570 |
|
|
2023
Q3 | $9.27M | Buy |
899,510
+72,834
| +9% | +$691K | ﹤0.01% | 2930 |
|
|
2023
Q2 | $6.82M | Buy |
826,676
+155,225
| +23% | +$929K | ﹤0.01% | 3160 |
|
|
2023
Q1 | $3.75M | Sell |
671,451
-522,530
| -44% | -$2.99M | ﹤0.01% | 3438 |
|
|
2022
Q4 | $5.91M | Buy |
1,193,981
+512
| +0% | +$2.11K | ﹤0.01% | 3224 |
|
|
2022
Q3 | $5.73M | Sell |
1,193,469
-152,384
| -11% | -$653K | ﹤0.01% | 3250 |
|
|
2022
Q2 | $3.46M | Sell |
1,345,853
-173,870
| -11% | -$652K | ﹤0.01% | 3554 |
|
|
2022
Q1 | $8.75M | Sell |
1,519,723
-80,152
| -5% | -$719K | ﹤0.01% | 3224 |
|
|
2021
Q4 | $24M | Buy |
1,599,875
+300,011
| +23% | +$5.46M | ﹤0.01% | 2742 |
|
|
2021
Q3 | $34.1M | Sell |
1,299,864
-204,928
| -14% | -$7.55M | ﹤0.01% | 2569 |
|
|
2021
Q2 | $75.2M | Buy |
1,504,792
+79,888
| +6% | +$3.58M | ﹤0.01% | 2155 |
|
|
2021
Q1 | $65.6M | Buy |
1,424,904
+40,273
| +3% | +$1.92M | ﹤0.01% | 2160 |
|
|
2020
Q4 | $59.3M | Buy |
1,384,631
+20,670
| +2% | +$785K | ﹤0.01% | 2113 |
|
|
2020
Q3 | $55.6M | Sell |
1,363,961
-17,464
| -1% | -$870K | ﹤0.01% | 1962 |
|
|
2020
Q2 | $75.6M | Buy |
1,381,425
+61,876
| +5% | +$3.54M | ﹤0.01% | 1802 |
|
|
2020
Q1 | $69M | Buy |
1,319,549
+41,213
| +3% | +$2.23M | ﹤0.01% | 1704 |
|
|
2019
Q4 | $62.2M | Buy |
1,278,336
+51,199
| +4% | +$2.4M | ﹤0.01% | 1995 |
|
|
2019
Q3 | $67.4M | Buy |
1,227,137
+139,502
| +13% | +$7.98M | ﹤0.01% | 1936 |
|
|
2019
Q2 | $54.3M | Sell |
1,087,635
-20,942
| -2% | -$1.04M | ﹤0.01% | 2060 |
|
|
2019
Q1 | $62.5M | Buy |
1,108,577
+65,705
| +6% | +$3.92M | ﹤0.01% | 1981 |
|
|
2018
Q4 | $66.5M | Buy |
1,042,872
+75,103
| +8% | +$5.32M | ﹤0.01% | 1885 |
|
|
2018
Q3 | $78.6M | Buy |
967,769
+62,267
| +7% | +$4.56M | ﹤0.01% | 1914 |
|
|
2018
Q2 | $57.8M | Buy |
905,502
+203,699
| +29% | +$9.99M | ﹤0.01% | 2062 |
|
|
2018
Q1 | $27.2M | Buy |
701,803
+139,598
| +25% | +$4.89M | ﹤0.01% | 2372 |
|
|
2017
Q4 | $15.8M | Buy |
562,205
+199,473
| +55% | +$5.84M | ﹤0.01% | 2599 |
|
|
2017
Q3 | $9.7M | Buy |
362,732
+125,768
| +53% | +$2.4M | ﹤0.01% | 2822 |
|
|
2017
Q2 | $3.57M | Buy |
236,964
+27,997
| +13% | +$378K | ﹤0.01% | 3205 |
|
|
2017
Q1 | $2.82M | Buy |
208,967
+38,720
| +23% | +$556K | ﹤0.01% | 3268 |
|
|
2016
Q4 | $2.55M | Buy |
+170,247
| New | +$2.18M | ﹤0.01% | 3281 |
|
Other funds holding TRHC
Vanguard Group's TRHC Position: Q4 2023 in Review
Vanguard Group sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q4 2023, closing a stake of 899,510 shares — an estimated $9.27M sold.
Vanguard Group first reported a position in TRHC in Q4 2016 and held it in 28 quarters. The position peaked at $78.6M in Q3 2018. 1 fund tracked by Wall St. Rank holds TRHC as of Q4 2023.
- Vanguard Group reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Vanguard Group sold 899,510 Tabula Rasa HealthCare, Inc. Common Stock shares in Q4 2023, an estimated $9.27M.
- Vanguard Group first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2016 and held it in 28 quarters.
- Vanguard Group's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $78.6M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q4 2023.
Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.